Akesobio set to launch $300m Hong Kong IPO

By Jonathan Breen
08 Apr 2020

Chinese biopharmaceuticals firm Akesobio is preparing to launch bookbuilding for its IPO next week, according to a source close to the deal.

JP Morgan and Morgan Stanley are running the show as the sponsors. The duo kicked off pre-marketing for the deal this week and are set to open books in the week of April 13.

The listing is expected to raise about $300m, said the source.

Akesobio is a clinical-state biopharmaceuticals ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial